Subscribe

The Improbable Resilience
of the Life Sciences TV Ad

Larry Dobrow

April 17, 2025

9 Minute Read

Read More

Articles

April 22, 2025
8 Minute Read

Fast Takeoff Versus Gradual Ramp-Up: The Scaling Hypothesis Comes to Pharma

Ahmed Elsayyad
April 17, 2025
9 Minute Read

The Improbable Resilience of the Life Sciences TV Ad

Larry Dobrow
April 10, 2025
7 Minute Read

Advancing Neurohealth: A Q&A with Alkermes CEO Richard Pops

Chase Feiger
April 3, 2025
7 Minute Read

‘No Innovation for Innovation’s Sake’: Inside Endo’s Spatial Computing Gambit

Larry Dobrow
March 27, 2025
8 Minute Read

Innovate or Become Obsolete: Pharma’s AI Imperative

Will McMahon, Director, Omnichannel Strategy, AstraZeneca
March 20, 2025
9 Minute Read

Building a First-Tier Pharma Culture: A Q&A with Jazz Pharmaceuticals CEO Bruce Cozadd

Chase Feiger
March 14, 2025
10 Minute Read

‘He Goes and I Follow’: NewAmsterdam’s BJ Jones and the Case for Purposeful Leadership in Life Sciences

Larry Dobrow
March 12, 2025
12 Minute Read

Five Years Later: Life Science Leaders Reflect on the Pandemic Era

Multiple Authors
March 5, 2025

Revolutionizing Diagnostics: A Q&A with Exact Sciences CEO Kevin Conroy

Chase Feiger
February 27, 2025
6 Minute Read

The Dawn of Cognitive Augmentation in Life Sciences

Ahmed Elsayyad
February 20, 2025

From Doctor to Drug Developer: A Q&A with NewAmsterdam CEO Dr. Michael Davidson

Chase Feiger
February 13, 2025
9 Minute Read

Is AI Literacy a Pharma and Healthcare Blind Spot?

Larry Dobrow
Load More

Kinara

Social

© 2025 Kinara. All rights reserved. Terms of Use. Privacy Policy.

Kinara